Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum Days for Lung Cancer Mutation Analysis Test by NGS

The report for the Lung Cancer Mutation Analysis Test by NGS can be obtained within 10-14 business days after the sample is received by the laboratory. Please note that this timeframe may vary depending on the specific laboratory and test conditions.

What are the prerequisites for the test Lung Cancer Mutation Analysis Test by NGS

  • Patient must have a confirmed diagnosis of lung cancer
  • Physician's order for the Lung Cancer Mutation Analysis Test by NGS
  • Specimen samples (tissue or blood) collected and properly labeled
  • Patient consent form signed
  • Insurance pre-authorization if required

What are the measure values for the test Lung Cancer Mutation Analysis Test by NGS

  • Gene Mutations Detected: EGFR, ALK, ROS1, BRAF, MET, RET
  • Test Sensitivity: 98%
  • Test Specificity: 99%
  • Limit of Detection: 0.1%
  • Sample Type: Tissue biopsy or blood sample

What does this test Lung Cancer Mutation Analysis Test by NGS identify?

  • EGFR gene mutations
  • ALK gene rearrangements
  • ROS1 gene rearrangements
  • BRAF gene mutations
  • KRAS gene mutations
  • HER2 gene mutations
  • RET gene rearrangements

Why is this test Lung Cancer Mutation Analysis Test by NGS taken?

The Lung Cancer Mutation Analysis Test by NGS is taken to identify specific genetic mutations in lung cancer patients. These mutations can help determine the most effective treatment options for individual patients. The test uses Next-Generation Sequencing (NGS) technology to analyze a wide range of genetic alterations that may be driving the growth of the cancer cells. This information can guide oncologists in selecting targeted therapies that are more likely to be successful in treating the patient's cancer.

No FAQs available.

Customer Google Rating